INFLAMATIONS
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (PubMed)
The endocannabinoid system: an emerging key player in inflammation (PubMed)
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice (PubMed)
Cannabinoids, endocannabinoids, and related analogs in inflammation (PubMed)
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor (PubMed)
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors (PubMed)
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis (PubMed)
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation (PubMed)
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement (PubMed)
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption (PubMed)
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation (PubMed)
Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death (PubMed)